Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Staging
18 results:

  • 1. Analysis of the MLH1, MLH2, MLH6, PMS2 genes and their correlations with clinical data in rectal mucinous adenocarcinoma.
    Graur F; Puia A; Mois E; Pop P; Berar M; Elisei R; Zaharie F; Nechita V; Rusu I; Buiga R; Puia C; Al Hajjar N
    Ann Ital Chir; 2022; 93():188-194. PubMed ID: 34807001
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathological, Immunohistochemical, and
    Mousavi M; Goodarzi MT; Kassaee SM; Jafari Heidarloo A; Fathi M
    Arch Iran Med; 2021 Feb; 24(2):86-93. PubMed ID: 33636974
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer.
    Lee CT; Chow NH; Chen YL; Ho CL; Yeh YM; Lin SC; Lin PC; Lin BW; Chu CA; Tsai HW; Lee JC
    Pathol Res Pract; 2021 Jan; 217():153288. PubMed ID: 33276219
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Different surgical outcome and follow-up status between dMMR and pMMR colorectal cancer patients who fulfilled with Amsterdam-II criteria.
    Sun CY; Chiang JM; Chen TC; Hung HY; You JF
    World J Surg Oncol; 2020 Aug; 18(1):195. PubMed ID: 32767993
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Endoscopic full thickness resection for early colon cancer in Lynch syndrome.
    Langers AMJ; Boonstra JJ; Hardwick JCH; van der Kraan J; Farina Sarasqueta A; Vasen HFA
    Fam Cancer; 2019 Jul; 18(3):349-352. PubMed ID: 31111311
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic values of detecting MSI phenotypes in colorectal carcinoma by immunohistochemical method compared to molecular investigation.
    Trabelsi M; Farah F; Blel A; Jaafoura MH; Kharrat M; Rammeh S
    Tunis Med; 2017 Dec; 95(12):229-236. PubMed ID: 29878286
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Microcystic, Elongated, and Fragmented Pattern Invasion in Ovarian Endometrioid Carcinoma: Immunohistochemical Profile and Prognostic Implications.
    Goldberg A; Hand L; DeCotiis D; Rosenblum N; Chan J
    Int J Gynecol Pathol; 2018 Jan; 37(1):44-51. PubMed ID: 28319570
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic screening in young women diagnosed with endometrial cancer.
    Pecorino B; Rubino C; Guardalà VF; Galia A; Scollo P
    J Gynecol Oncol; 2017 Jan; 28(1):e4. PubMed ID: 27670258
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Distinct Clinicopathological Patterns of Mismatch Repair Status in colorectal cancer Stratified by KRAS Mutations.
    Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J
    PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer?
    Hur H; Kim NK; Min BS; Baik SH; Lee KY; Koom WS; Ahn JB; Kim H
    Dis Colon Rectum; 2014 May; 57(5):592-601. PubMed ID: 24819099
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Lynch syndrome from a surgeon perspective: retrospective study of clinical impact of mismatch repair protein expression analysis in colorectal cancer patients less than 50 years old.
    Baiocchi GL; Portolani N; Vermi W; Baronchelli C; Gheza F; Zogno C; Scaglia A; Marchina E; Tiberio GA; Giulini SM
    BMC Surg; 2014 Feb; 14():9. PubMed ID: 24533633
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Incidence and histological features of colorectal cancer in the Northern Cape Province, South Africa.
    Wentink MQ; Räkers M; Stupart DA; Algar U; Ramesar R; Goldberg PA
    S Afr J Surg; 2010 Nov; 48(4):109-13. PubMed ID: 21542398
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. SPARCL1, Shp2, msh2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer.
    Yu SJ; Yu JK; Ge WT; Hu HG; Yuan Y; Zheng S
    World J Gastroenterol; 2011 Apr; 17(15):2028-36. PubMed ID: 21528083
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds.
    Grindedal EM; Renkonen-Sinisalo L; Vasen H; Evans G; Sala P; Blanco I; Gronwald J; Apold J; Eccles DM; Sánchez AA; Sampson J; Järvinen HJ; Bertario L; Crawford GC; Stormorken AT; Maehle L; Moller P
    J Med Genet; 2010 Feb; 47(2):99-102. PubMed ID: 19635727
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Analysis of hMLH1 and hmsh2 expression in cisplatin-treated ovarian cancer patients.
    Magnowska M; Surowiak P; Nowak-Markwitz E; Michalak M; Magnowski P; Rokita W; Kedzia H; Zabel M; Spaczyński M
    Ginekol Pol; 2008 Dec; 79(12):826-34. PubMed ID: 19175039
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Survival analysis in families affected by hereditary non-polyposis colorectal cancer.
    Percesepe A; Benatti P; Roncucci L; Sassatelli R; Fante R; Ganazzi D; Bellacosa A; Genuardi M; Neri G; Viel A; Ponz de Leon M
    Int J Cancer; 1997 May; 71(3):373-6. PubMed ID: 9139871
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Microsatellite alterations in plasma DNA of small cell lung cancer patients.
    Chen XQ; Stroun M; Magnenat JL; Nicod LP; Kurt AM; Lyautey J; Lederrey C; Anker P
    Nat Med; 1996 Sep; 2(9):1033-5. PubMed ID: 8782463
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Microsatellite instability in primary and metastatic colorectal cancers.
    Ishimaru G; Adachi J; Shiseki M; Yamaguchi N; Muto T; Yokota J
    Int J Cancer; 1995 Jun; 64(3):153-7. PubMed ID: 7622302
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.